ATNM
Actinium Pharmaceuticals, Inc.
Key Financials
Revenue
$90000
↑ 11.1%
Net Income
$-33887000
↑ 11.4%
Gross Profit
$0
NaN%
EPS (Diluted)
$-1.09
↑ 14.2%
Operating Income
$-36247000
↑ 13.9%
Total Assets
$51.8M
↓ 32.7%
Total Liabilities
$43.9M
↓ 0.5%
Shareholders' Equity
$7.8M
↓ 76.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ATNM |
| Company Name | Actinium Pharmaceuticals, Inc. |
| CIK | 1388320 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (646) 677-3870 |